Literature DB >> 30032272

Undetectable = Untransmittable and Your Health: The Personal Benefits of Early and Continuous Therapy for HIV Infection.

Mark J Siedner1,2,3,4, Virginia Triant1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30032272      PMCID： PMC6306014          DOI： 10.1093/infdis/jiy445

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  35 in total

1.  Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.

Authors:  Rebeccah A McKibben; Joseph B Margolick; Steven Grinspoon; Xiuhong Li; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Richard T George; Lisa P Jacobson; Matthew Budoff; Russell P Tracy; Todd T Brown; Wendy S Post
Journal:  J Infect Dis       Date:  2014-10-30       Impact factor: 5.226

2.  Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.

Authors:  Patrice Severe; Marc Antoine Jean Juste; Alex Ambroise; Ludger Eliacin; Claudel Marchand; Sandra Apollon; Alison Edwards; Heejung Bang; Janet Nicotera; Catherine Godfrey; Roy M Gulick; Warren D Johnson; Jean William Pape; Daniel W Fitzgerald
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

3.  Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.

Authors:  Troels Bygum Knudsen; Gideon Ertner; Janne Petersen; Holger Jon Møller; Søren K Moestrup; Jesper Eugen-Olsen; Gitte Kronborg; Thomas Benfield
Journal:  J Infect Dis       Date:  2016-06-28       Impact factor: 5.226

4.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

5.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

6.  Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system.

Authors:  Virginia A Triant; Susan Regan; Hang Lee; Paul E Sax; James B Meigs; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

7.  The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis.

Authors:  Álvaro H Borges; Jacqueline Neuhaus; Shweta Sharma; James D Neaton; Keith Henry; Olga Anagnostou; Teresa Staub; Sean Emery; Jens D Lundgren
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

8.  Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14.

Authors:  Gema Méndez-Lagares; M Concepción Romero-Sánchez; Ezequiel Ruiz-Mateos; Miguel Genebat; Sara Ferrando-Martínez; María Á Muñoz-Fernández; Yolanda M Pacheco; Manuel Leal
Journal:  J Infect Dis       Date:  2013-01-15       Impact factor: 5.226

9.  Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Jan van Lunzen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; David Asboe; Pompeyo Viciana; Félix Gutiérrez; Bonaventura Clotet; Christian Pradier; Jan Gerstoft; Rainer Weber; Katarina Westling; Gilles Wandeler; Jan M Prins; Armin Rieger; Marcel Stoeckle; Tim Kümmerle; Teresa Bini; Adriana Ammassari; Richard Gilson; Ivanka Krznaric; Matti Ristola; Robert Zangerle; Pia Handberg; Antonio Antela; Sris Allan; Andrew N Phillips; Jens Lundgren
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

10.  Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England.

Authors:  Douglas S Krakower; Catherine E Oldenburg; Jennifer A Mitty; Ira B Wilson; Ann E Kurth; Kevin M Maloney; Donna Gallagher; Kenneth H Mayer
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240
View more
  3 in total

Review 1.  COVID-19 outcomes in HIV patients: A review.

Authors:  Abdullahi Tunde Aborode; Titilayo Mabel Olotu; O B Oyetunde; Abayomi Oyeyemi Ajagbe; Mariam Ayoola Mustapha; Ayah Karra-Aly; Christian Inya Oko
Journal:  Ann Med Surg (Lond)       Date:  2022-05-16

2.  Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review.

Authors:  T J Cooper; B L Woodward; S Alom; A Harky
Journal:  HIV Med       Date:  2020-07-15       Impact factor: 3.094

3.  Perspectives of HIV-positive and -negative people who use drugs regarding the criminalization of HIV non-disclosure in Canada: a qualitative study.

Authors:  Cara Ng; Koharu Loulou Chayama; Andrea Krüsi; Will Small; Rod Knight
Journal:  BMC Public Health       Date:  2020-08-10       Impact factor: 3.295
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.